Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?
| Errataetall: |
CommentOn: JAMA Netw Open. 2021 Nov 1;4(11):e2133090. - PMID 34779847 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
JAMA network open - 4(2021), 11 vom: 01. Nov., Seite e2136510 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hoertel, Nicolas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
01K63SUP8D |
|---|
| Anmerkungen: |
Date Completed 18.11.2021 Date Revised 07.12.2022 published: Electronic CommentOn: JAMA Netw Open. 2021 Nov 1;4(11):e2133090. - PMID 34779847 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamanetworkopen.2021.36510 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333176073 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333176073 | ||
| 003 | DE-627 | ||
| 005 | 20231225221117.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamanetworkopen.2021.36510 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1110.xml |
| 035 | |a (DE-627)NLM333176073 | ||
| 035 | |a (NLM)34779851 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hoertel, Nicolas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.11.2021 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentOn: JAMA Netw Open. 2021 Nov 1;4(11):e2133090. - PMID 34779847 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antidepressive Agents |2 NLM | |
| 650 | 7 | |a Serotonin Uptake Inhibitors |2 NLM | |
| 650 | 7 | |a Fluoxetine |2 NLM | |
| 650 | 7 | |a 01K63SUP8D |2 NLM | |
| 650 | 7 | |a Fluvoxamine |2 NLM | |
| 650 | 7 | |a O4L1XPO44W |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA network open |d 2018 |g 4(2021), 11 vom: 01. Nov., Seite e2136510 |w (DE-627)NLM289300517 |x 2574-3805 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2021 |g number:11 |g day:01 |g month:11 |g pages:e2136510 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamanetworkopen.2021.36510 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2021 |e 11 |b 01 |c 11 |h e2136510 | ||